bw 245c has been researched along with transforming growth factor beta in 2 studies
Studies (bw 245c) | Trials (bw 245c) | Recent Studies (post-2010) (bw 245c) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
96 | 3 | 10 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huaux, F; Lison, D; Uwambayinema, F; van den Brule, S; Wallemme, L | 1 |
Ayabe, S; Hori, M; Kida, T; Murata, T; Ozaki, H | 1 |
2 other study(ies) available for bw 245c and transforming growth factor beta
Article | Year |
---|---|
The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cells, Cultured; Collagen; Female; Fibroblasts; Humans; Hydantoins; Interleukin-13; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, Prostaglandin; Transforming Growth Factor beta | 2010 |
Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor.
Topics: Cells, Cultured; Collagen; Cyclic AMP; Fibroblasts; Humans; Hydantoins; Lung; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Transforming Growth Factor beta | 2013 |